ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 149 filers reported holding ATARA BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,104,125 | -16.9% | 4,124,409 | -9.6% | 0.00% | 0.0% |
| Q2 2023 | $7,344,826 | -62.0% | 4,562,004 | -31.6% | 0.00% | -75.0% |
| Q1 2023 | $19,347,939 | -5.5% | 6,671,703 | +6.9% | 0.00% | -20.0% |
| Q4 2022 | $20,479,050 | +13.8% | 6,243,613 | +31.2% | 0.01% | +25.0% |
| Q3 2022 | $17,988,000 | -21.4% | 4,758,680 | +62.0% | 0.00% | -20.0% |
| Q2 2022 | $22,890,000 | -32.3% | 2,938,296 | -19.2% | 0.01% | -28.6% |
| Q1 2022 | $33,798,000 | -16.4% | 3,638,106 | +41.9% | 0.01% | -12.5% |
| Q4 2021 | $40,417,000 | -21.4% | 2,564,527 | -10.8% | 0.01% | -27.3% |
| Q3 2021 | $51,450,000 | +27.4% | 2,874,277 | +10.6% | 0.01% | +22.2% |
| Q2 2021 | $40,395,000 | +32.6% | 2,597,710 | +22.4% | 0.01% | +12.5% |
| Q1 2021 | $30,468,000 | -41.4% | 2,121,735 | -19.8% | 0.01% | -38.5% |
| Q4 2020 | $51,950,000 | +26.6% | 2,646,479 | -16.4% | 0.01% | +8.3% |
| Q3 2020 | $41,021,000 | -20.2% | 3,165,214 | -10.3% | 0.01% | -25.0% |
| Q2 2020 | $51,384,000 | +854.6% | 3,526,716 | +457.5% | 0.02% | +700.0% |
| Q1 2020 | $5,383,000 | -22.6% | 632,645 | +49.7% | 0.00% | 0.0% |
| Q4 2019 | $6,959,000 | +22.6% | 422,532 | +5.1% | 0.00% | 0.0% |
| Q3 2019 | $5,676,000 | -0.8% | 401,943 | +41.3% | 0.00% | 0.0% |
| Q2 2019 | $5,719,000 | -44.5% | 284,391 | +9.7% | 0.00% | -33.3% |
| Q1 2019 | $10,309,000 | -8.4% | 259,339 | -19.9% | 0.00% | -25.0% |
| Q4 2018 | $11,249,000 | -33.7% | 323,812 | -21.1% | 0.00% | 0.0% |
| Q3 2018 | $16,969,000 | +9.4% | 410,379 | -2.8% | 0.00% | 0.0% |
| Q2 2018 | $15,513,000 | +129.7% | 422,103 | +143.7% | 0.00% | +100.0% |
| Q1 2018 | $6,755,000 | +1740.6% | 173,194 | +754.6% | 0.00% | – |
| Q4 2017 | $367,000 | +11.2% | 20,266 | +1.6% | 0.00% | – |
| Q3 2017 | $330,000 | +61.8% | 19,956 | +36.9% | 0.00% | – |
| Q2 2017 | $204,000 | -95.1% | 14,578 | -92.8% | 0.00% | -100.0% |
| Q1 2017 | $4,135,000 | +938.9% | 201,214 | +617.9% | 0.00% | – |
| Q4 2016 | $398,000 | -41.1% | 28,030 | -11.3% | 0.00% | – |
| Q3 2016 | $676,000 | +86.2% | 31,595 | +96.1% | 0.00% | – |
| Q2 2016 | $363,000 | -59.4% | 16,110 | -43.3% | 0.00% | – |
| Q3 2015 | $893,000 | -36.4% | 28,388 | -45.9% | 0.00% | – |
| Q4 2014 | $1,405,000 | – | 52,508 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $1,480,000 | 7.58% |
| Redmile Group, LLC | 6,280,813 | $9,295,603 | 0.44% |
| Arctis Global LLC | 397,046 | $587,628 | 0.32% |
| Baupost Group | 9,773,616 | $14,465 | 0.28% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 230,000 | $413,400 | 0.24% |
| MAVERICK CAPITAL LTD | 6,290,713 | $9,310,255 | 0.21% |
| 683 Capital Management, LLC | 1,200,000 | $1,776,000 | 0.14% |
| STALEY CAPITAL ADVISERS INC | 1,000,000 | $1,480,000 | 0.08% |
| WASATCH ADVISORS LP | 8,399,229 | $12,430,859 | 0.08% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $777,000 | 0.07% |